[TREATMENT OF LIPID METABOLISM DISORDERS WITH ETHYL ALPHA-(P-CHLOROPHENOXY)-ISOBUTYRATE].
D000924:Anticholesteremic Agents; D002087:Butyrates; D006801:Humans; D058610:Isobutyrates; D050356:Lipid Metabolism; D052439:Lipid Metabolism Disorders; D008064:Lipidoses; D008659:Metabolic Diseases; D014652:Vascular Diseases
D000924:Anticholesteremic Agents; D002087:Butyrates; D058610:Isobutyrates
ANTICHOLESTEREMIC AGENTS; BUTYRATES; LIPID METABOLISM; LIPOIDOSIS; METABOLIC DISEASES; VASCULAR DISEASES
BEHANDLUNG VON LIPIDSTOFFWECHSELSTOERUNGEN MIT ATHYL-X-P-CHLORPHENOXYISOBUTYRAT.